Corcept Therapeutics

CORT

NASDAQHealth Care

Income Statement

Total Revenue$675.04M

Gross Profit$664.16M

Operating Income$136.95M

EBITDA$136.79M

EBIT$135.46M

Pre-tax Income$12.13M

Net Income$139.71M

Cash Equivalent$135.82M

Total Debt$4.87M

Book Value$615.63M

Book Value Per Share5.91

Return on Equity (ROE)+20.78%

Return on Assets (ROA)+16.80%

Return on Invested Capital (ROI)+20.78%

Net Profit Margin+20.92%

Current Ratio3.35

Quick Ratio3.19

Long-Term Debt / Equity0.00